U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472075) titled 'Melatonin Versus Placebo for Bipolar Disorder' on March 01.
Brief Summary: The objective with this study is to conduct a 6-month RCT comparing effects of add-on melatonin versus add-on placebo on mood stabilisation and other critical patient outcomes in patients with BD and to test whether principal effects are antimanic, antidepressant and/or prophylactic against relapse
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Bipolar Affective Disorder
Intervention:
DRUG: Melatonin
Oral: Melatonin capsule 6 mg, 1 capsule/day
DRUG: Placebo
Oral Placebo capsule, 1 capsule/day
Recruitment Status: NOT_YET_RECRUIT...